Effects of long-term exposure to δ9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions

Molecular Brain Research

Volumn 62, Issue 2, 1998, Pages 141-149

  Zhuang, Shou yuan ^a   Kittler, Josef ^a   Grigorenko, Elena V ^a   Kirby, M Todd ^a   Sim, Laura J ^a   Hampson, Robert E ^a   Childers, Steven R ^a   Deadwyler, Sam A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabinoid receptor (CB1) mRNA; Chronic 9 THC; Rat brain; Receptor desensitization; Semi quantitative RT PCR; Tolerance

Indexed keywords

CANNABINOID RECEPTOR; DRONABINOL; MESSENGER RNA;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; BRAIN REGION; CONTROLLED STUDY; DRUG EXPOSURE; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BRAIN CHEMISTRY; CEREBELLUM; CORPUS STRIATUM; GENE EXPRESSION REGULATION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HIPPOCAMPUS; NERVE TISSUE PROTEINS; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER; TETRAHYDROCANNABINOL; TIME FACTORS;

EID: 0032570042     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00232-0     Document Type: Article

References (37)

1. 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain. Pharmacol. Biochem. Behav. 46:1993;575-579.
2. Breivogel C.S., Sim L.J., Childers S.R. Regional differences in cannabinoid receptor/G-protein coupling in rat brain. J. Pharmacol. Exp. Ther. 282:1997;1632-1642.
3. 9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptor and cannabinoid receptor-activated G-proteins in rat brain, J. Neurochem., 1998, in press.
4. Carlini E.A. Tolerance of chronic administration of Cannabis sativa (marihuana) in rats. Pharmacology. 1:1968;135-142.
5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid quanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
6. Daunais J.B., McGinty J.F. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse. 18:1994;35-45.
7. S.A. Deadwyler, R.E. Hampson, S.R. Childers, Functional significance of cannabinoid receptors in brain, in: R.G. Pertwee (Ed.), Cannabinoid Receptors, Academic Press, London, 1995, pp. 205-231.
8. 9-THC following 35 days of exposure. Neurol. Res. Commun. 17:1995;9-18.
9. Dill J.A., Howlett A.C. Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs. J. Pharmacol. Exp. Ther. 244:1988;1157-1163.
10. Fan F., Tao Q., Abood M., Martin B.R. Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice. Brain Res. 706:1996;13-20.
11. 9-tetrahydrocannabinol. Brain Res. 697:1995;83-90.
12. W. Hall, N. Solowij, J. Lemon, The Health and Psychological Consequences of Cannabis Use, Australian Govt. Publ. Service, Canberra, 1994.
13. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA. 87:1990;1932-1936.
14. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11:1991;563-583.
15. Howlett A.C. Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes. Mol. Pharmacol. 27:1985;429-436.
16. Jansen E.M., Haycock D.A., Ward S.J., Seybold V.S. Distribution of cannabinoid receptors in brain determined with aminoalkylindoles. Brain Res. 575:1992;93-102.
17. Kluttz B.W., Vrana K.E., Dworkin S.I., Childers S.R. Effects of morphine on forskolin-stimulated pro-enkephalin mRNA levels in rat striatum: a model for acute and chronic opioid actions in brain. Brain Res. Mol. Brain Res. 32:1995;313-320.
18. Kosofsky B.E., Genova L.M., Hyman S.E. Postnatal age defines specificity of immediate early gene induction by cocaine in developing rat brain. J. Comp. Neurol. 351:1995;27-40.
19. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA. 89:1992;3825-3829.
20. Mailleux P., Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience. 48:1992;655-668.
21. Matsuda L.A., Bonner T.I., Lolait J. Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol. 327:1993;535-550.
22. McMillan D.E., Dewey W.L., Harris L.S. Characteristics of tetrahydrocannabinol tolerance. Ann. New York Acad. Sci. 191:1971;83-99.
23. Moratalla R., Robertson H.A., Graybiel A.M. Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum. J. Neurosci. 12:1992;2609-2622.
24. Oviedo A., Glowa J., Herkenham M. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Brain Res. 616:1993;293-302.
25. 9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. Br. J. Pharmacol. 110:1993;1483-1490. [published erratum appears in Br. J. Pharmacol., 111 (3) (1994 March), 968].
26. 2 dopamine receptor mRNA expression after chronic cocaine in the nucleus accumbens and striatum of the rat. Eur. Neuropsychopharmacol. 5:1995;465-469.
27. Riva M.A., Tascedda F., Lovati E., Racagni G. Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs. Brain Res. Mol. Brain Res. 50:1997;136-142.
28. 9-tetrahydrocannabinol. Pharmacol. Biochem. Behav. 47:1994;33-40.
29. 9-tetrahydrocannabinol. Pharmacol. Biochem. Behav. 51:1995;731-737.
30. 9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Brain Res. Mol. Brain Res. 46:1997;100-108.
31. Rubino T., Massi P., Patrini G., Venier I., Giagnoni G., Parolaro D. Chronic CP 55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study. NeuroReport. 5:1994;2493-2496.
32. Rubino T., Patrini G., Parenti M., Massi P., Parolaro D. Chronic treatment with a synthetic cannabinoid CP 55,940 alters G-protein expression in the rat central nervous system. Brain Res. Mol. Brain Res. 44:1997;191-197.
33. 35S ]thio]-triphosphate binding Proc. Natl. Acad. Sci. USA. 92:1995;7242-7246.
34. 35S ]GTP-γ-S autoradiography in rat brain J. Neurosci. 16:1996;8057-8066.
35. N. Solowij, Cannabis and Cognitive Functioning, Cambridge University Press, UK, 1998.
36. 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Eur. J. Pharmacol. 280:1995;R13-R15.
37. 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors. Brain Res. 544:1991;145-149.